Smoking: Clinical Trials

137 trials for Smoking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 12 recruiting, 9 terminated, 8 unknown. 137 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4137Completed 95, Recruiting 12, Terminated 9, Unknown 8, Not yet recruiting 5, Withdrawn 5, Active not recruiting 2, Enrolling by invitation 1

Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking

Trials (filtered) newest first · largest first

All 137 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Evaluating an Innovative Tobacco Treatment Approach for Veterans in Substance Use Treatment
Healthy Changes Nicotine Replacement Therapy (NRT), Cessation Treatment Nicotine Replacement Therapy (NRT), Cessation Treatment Counseling - Cigarette Smoking, Veterans
Phase 4Not yet recruitingVA Office of Research and Development1122027-04-012026-09-14
Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts Among Regular Electronic Cigarette Use
Nicotine Replacement Therapies, Brief Behavioral Counseling - E Cigarette Use, Cessation, Tobacco
Phase 4Not yet recruitingWest Virginia University1002026-09-012026-08-26
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge, Cessation-Phase Combination Nicotine Replacement Therapy (NRT) - Veterans, Tobacco Use Disorder
Phase 4RecruitingVA Office of Research and Development4002026-08-172026-08-31
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Varenicline, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham - Nicotine Dependence, Transcranial Magnetic Stimulation
Phase 4RecruitingMassachusetts General Hospital302026-07-022026-09-15
Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking
Nicotine replacement therapy patches, Oral nicotine pouches - Smoking ( Cigarette)
Phase 4Enrolling by invitationMedical University of South Carolina102026-06-262026-07-06
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
transdermal nicotine replacement therapy - Smoking
Phase 4RecruitingDuke University6002026-05-062026-07-23
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
Daridorexant 50 mg, Placebo - Smoking, Nicotine
Phase 4Not yet recruitingLegacy Health System442026-02-102026-01-09
tDCS Plus Varenicline for Smoking Cessation
Active Transcranial Direct Current Stimulation (tDCS), Varenicline 1mg BID, Sham Transcranial Direct Current Stimulation (tDCS) - Nicotine Dependence, Tobacco Smoking
Phase 4RecruitingCentre for Addiction and Mental Health1602025-03-102025-08-12
E-cigarette Cessation in Adults Who Co-use Cannabis
Varenicline Pill, Contingency management, Counseling - Nicotine Dependence, Tobacco Use Disorder
Phase 4RecruitingMedical University of South Carolina1052025-02-192026-06-12
Addiction Potential of Very Low Nicotine Filtered Little Cigars
Reduced Nicotine Content Cigars, Normal nicotine content cigar, Usual brand cigar - Smoking (Tobacco) Addiction
Phase 4RecruitingOhio State University Comprehensive Cancer Center502025-02-132026-10-29
Beta-Adrenergic Modulation of Drug Cue Reactivity
Propranolol, Nicotine Patch, Placebo Propranolol - Tobacco Use Disorder, Nicotine Dependence
Phase 4RecruitingUniversity of Oklahoma802024-11-262026-04-28
The Avenues Study: Dual Use Cessation
Varenicline, Nicotine patch, Dual Focused Cessation Counseling - Smoking Cessation, Electronic Cigarette Use
Phase 4RecruitingUniversity of Wisconsin, Madison5002024-09-242026-10-07
Tobacco Cessation at FDNY
opt out enrollment, tailored counseling, varenicline started prior to target quit date, opt in enrollment, non-tailored counseling, varenicline started prior to target quit date - Tobacco Use, Tobacco Smoking
Phase 4CompletedAlbert Einstein College of Medicine232024-05-312026-11-05
Smoking Cessation Program in the Construction Sector
Nicorette, Tobacco Quit-line, Brief Behavioral Counseling - Smoking Cessation, Tobacco Use Cessation
Phase 4Active not recruitingUniversity of Miami6082024-04-102026-08-21
Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
Brainsway H4 deep rTMS coil and Brainsway stimulator system - Smoking
Phase 4RecruitingCentre for Addiction and Mental Health402024-03-302026-03-27
Treating Caregivers Who Smoke at AFCH
Nicotine Replacement Product - Smoking, Smoking Cessation
Phase 4CompletedUniversity of Wisconsin, Madison232024-03-052026-04-16
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
Bupropion, Nicotine replacement therapy (Nicotine patches) - Tobacco Smoking, Tobacco Withdrawal
Phase 4UnknownNational Institute of Respiratory Diseases, Mexico1342024-01-152024-02-23
Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
Clonidine controlled-release patch, Amlodipine - Hypertension
Phase 4Not yet recruitingJing Liu922024-01-012024-01-17
BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
Text message smoking treatment, Nicotine replacement therapy sampling, Wisconsin Tobacco QuitLine Referral - Quitting Smoking, Smoking Cessation
Phase 4CompletedUniversity of Wisconsin, Madison123762023-07-242026-06-26

Showing 20 of 137. Sign in to see all of them.

Narrower conditions

Smoking Cessation (54)  ·  Tobacco Use Disorder (39)  ·  Cigarette Smoking (25)  ·  Tobacco Smoking (15)  ·  Vaping (14)  ·  Schizophrenia (9)  ·  Alcoholism (8)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Smoking Reduction (5)  ·  Tobacco Use (5)  ·  Substance-Related Disorders (4)  ·  Tobacco Use Cessation (4)  ·  Asthma (3)  ·  Behavior, Addictive (3)

Broader conditions

Behavior (137)  ·  Mental Disorders (60)  ·  Health Behavior (57)  ·  Chemically-Induced Disorders (50)  ·  Substance-Related Disorders (46)  ·  Tobacco Use (35)  ·  Tobacco Smoking (24)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Pathologic Processes (11)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (9)  ·  Alcohol-Related Disorders (8)  ·  Disease Attributes (8)  ·  Respiratory Tract Diseases (8)  ·  Vascular Diseases (8)

Interventions

Tobacco Use Cessation Devices (38)  ·  Varenicline (37)  ·  Nicotine Replacement Therapy (15)  ·  Nicotine Chewing Gum (14)  ·  Bupropion (13)  ·  Nicotine (11)  ·  Counseling (7)  ·  Motivational Interviewing (5)  ·  Ethanol (4)  ·  Sugars (4)  ·  Behavior Therapy (3)  ·  Cognitive Behavioral Therapy (3)  ·  Naltrexone (3)  ·  Transdermal Patch (3)  ·  Chewing Gum (2)

Sponsors

University of Wisconsin, Madison (18)  ·  Centre for Addiction and Mental Health (8)  ·  Massachusetts General Hospital (8)  ·  Duke University (7)  ·  VA Office of Research and Development (5)  ·  University of Miami (4)  ·  Yale University (4)  ·  Johns Hopkins University (3)  ·  Mayo Clinic (3)  ·  University of California, San Francisco (3)  ·  University of Pennsylvania (3)  ·  Medical University of South Carolina (2)  ·  Nathan Kline Institute for Psychiatric Research (2)  ·  Pfizer (2)  ·  Swedish Match AB (2)

Countries

United States (99)  ·  Canada (12)  ·  China (4)  ·  France (4)  ·  Germany (4)  ·  Brazil (3)  ·  Mexico (3)  ·  Spain (3)  ·  Switzerland (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Croatia (2)  ·  Czechia (2)  ·  Hong Kong (2)  ·  Italy (2)

Top investigators

Taghrid Asfar, MD (3)  ·  Timothy B Baker, PhD (3)  ·  Anne M. Joseph, MD MPH (2)  ·  Eden Evins, MD (2)  ·  Jason A Oliver, PhD (2)  ·  Jessica Cook, PhD (2)  ·  Laurie A Zawertailo, PhD (2)  ·  Megan E Piper, PhD (2)  ·  Michael C Fiore, MD, MPH, MBA (2)  ·  Nancy A Rigotti, MD (2)  ·  Peter Selby, MD, MHSc (2)  ·  Randi Schuster, PhD (2)  ·  Robin Mermelstein, PhD (2)  ·  Sarah M. Wilson, PhD (2)

Results publications

PMID 37142273, PMID 37230961, PMID 39868569, PMID 17874878, PMID 34611902, PMID 37335995, PMID 10191796, PMID 10417762, PMID 10493090, PMID 10510989, PMID 10581887, PMID 10740940, PMID 10748642, PMID 10791509, PMID 10812284, PMID 10885042, PMID 10901493, PMID 11176814, PMID 11236847, PMID 11260806, PMID 11390919, PMID 11516593, PMID 12010856, PMID 1202204, PMID 12028847, PMID 12047734, PMID 12438835, PMID 12492263, PMID 12814497, PMID 14525940, PMID 1453243, PMID 14636967, PMID 15007373, PMID 15010446, PMID 15023708, PMID 1511534, PMID 15364185, PMID 15370156, PMID 15370939, PMID 15533910, PMID 15541431, PMID 15561445, PMID 15586837, PMID 15820329, PMID 15900212, PMID 15925263, PMID 16123753, PMID 1613610, PMID 16402081, PMID 16402128

NIH funding

P01CA180945 (3), P50CA143188 (3), R01AA011197 (2), R01DA052583 (2), 1RC1CA144382-01 (1), 2023 (1), K01DA043413 (1), K24DA030301 (1), P50CA084718 (1), P50CA084724 (1), P50DA019706 (1), P50HL084945 (1), R01AA011124 (1), R01AA011210 (1), R01AA011216 (1)